Q1 2011

Filed May 9, 2011 · 10-Q · 39 days after period end · 0000950123-11-047522

Q1 2011 · 10-Q

Revenue

$10.67M

no prior Q1 2010 on file

Net Income

$721.16K

no prior Q1 2010 on file

EPS Diluted

$0.03

no prior Q1 2010 on file

Operating Income$1,408,001—

Operating Cash Flow

Same quarter

no prior Q1 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Mar 31, 2011 · filed May 9, 2011 · 39 d after period end

Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR